The Successful Sequential Use of Plerixafor and Eltrombopag For Hematopoietic Cell Transplantation in a Child With High-risk Neuroblastoma
We describe a case of a child with high-risk neuroblastoma, for whom plerixafor and eltrombopag were used as an effective and safe supportive therapy.
Source: Journal of Pediatric Hematology Oncology - Category: Hematology Tags: Online Articles: Clinical and Laboratory Observations Source Type: research
More News: Brain | Cancer & Oncology | Chemotherapy | Children | Filgrastim | Hematology | Laboratory Medicine | Neulasta | Neupogen | Neuroblastoma | Neurology | Pediatrics | Stem Cell Therapy | Stem Cells | Thrombocytopenia | Transplants